BackProMIS Neurosciences Overview

ProMIS Neurosciences Receivables

Track ProMIS Neurosciences's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00
↓ 100.00% YoYΔ $-29484.00 vs prior year quarter

Peer trimmed avg / median

Loading

ProMIS Neurosciences Receivables History

Loading

ProMIS Neurosciences vs. peers: Receivables Comparison

Loading

ProMIS Neurosciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

ProMIS Neurosciences (PMN) FAQ

ProMIS Neurosciences (PMN) currently reports a receivables of $0 as of June 2026. That compares with $29K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore ProMIS Neurosciences's receivables history and peer comparisons.

ProMIS Neurosciences's receivables decreased from $29K to $0 — a 100.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ProMIS Neurosciences reported $0 in receivables as of June 2026. That compares with $29K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ProMIS Neurosciences, and consider following PMN for alerts when major investors trade the stock.

ProMIS Neurosciences is classified in the Healthcare sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PMN with unrelated industries.